Literature DB >> 1914092

Left ventricular regional relaxation and its nonuniformity in hypertrophic nonobstructive cardiomyopathy.

W Hayashida1, T Kumada, F Kohno, M Noda, N Ishikawa, J Kojima, Y Himura, C Kawai.   

Abstract

BACKGROUND: Regional nonuniformity has been suggested to be closely related to left ventricular (LV) relaxation in diseased heart. The purpose of the present study was to assess LV global and regional relaxation in patients with nonobstructive hypertrophic cardiomyopathy (HCM). METHODS AND
RESULTS: Left ventriculography was conducted simultaneously with pressure micromanometry in 10 normal control subjects and 11 patients with nonobstructive HCM. LV silhouettes in the right anterior oblique projection were divided into eight regions, and regional wall stress during isovolumic relaxation was computed for six regions from the midventricle to the apex. In HCM patients, isovolumic relaxation time (IRT) and the time constant of LV pressure decrease (Tp) were greater than in control subjects (IRT, 84 +/- 13 versus 66 +/- 6 msec; Tp, 51 +/- 8 versus 36 +/- 5 msec, respectively; p less than 0.01). In HCM patients, the (-)dP/dt upstroke pattern was convex-downward, and dP/dt(20/60), the ratio of dP/dt values 20 and 60 msec after peak (-)dP/dt, was less than in control subjects (1.46 +/- 0.16 versus 2.15 +/- 0.14, p less than 0.01). These findings suggest that there is impaired LV relaxation in HCM patients. End-systolic regional wall stress was lower, and the time constant of regional stress decrease (Tst) was prolonged for each region in HCM patients compared with control subjects. In the HCM group, Tst tended to be more prolonged in regions with increased wall thickness than in regions with normal wall thickness (60 +/- 15 versus 50 +/- 11 msec, p less than 0.01). The coefficient of variation for Tst values in six areas of the left ventricle was calculated in each subject and was greater in HCM patients than in control subjects (13 +/- 7% versus 7 +/- 3%, p less than 0.05), indicating regional nonuniformity in Tst during isovolumic relaxation in HCM patients.
CONCLUSIONS: Significant correlations existed between the coefficients of variation for Tst and Tp (r = 0.80, p less than 0.01), IRT (r = 0.79, p less than 0.01), and dP/dt(20/60) (r = -0.67, p less than 0.05) in the HCM group. Thus, regional nonuniformity is closely related to the impairment of LV relaxation in HCM.

Entities:  

Mesh:

Year:  1991        PMID: 1914092     DOI: 10.1161/01.cir.84.4.1496

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Regional differences in shape and load in normal and diseased hearts studied by three dimensional tagged magnetic resonance imaging.

Authors:  Y F Petrank; S J Dong; J Tyberg; S Sideman; R Beyar
Journal:  Int J Card Imaging       Date:  1999-08

2.  Effect of regional myocardial perfusion abnormalities on regional myocardial early diastolic function in patients with hypertrophic cardiomyopathy.

Authors:  H Yamanari; M Kakishita; Y Fujimoto; K Hashimoto; T Kiyooka; Y Katayama; F Otsuka; T Emori; S Uchida; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

3.  Heterogeneity of apex-to-base dispersion in diastolic lengthening is related to impaired global left ventricular relaxation in patients with hypertrophic cardiomyopathy.

Authors:  Takeo Tanaka; Kazuya Murata; Eizo Akagawa; Yasuaki Wada; Shinichi Okuda; Takehisa Susa; Yoshio Nose; Hiroko Yoshino; Chikage Kihara; Masunori Matsuzaki
Journal:  J Echocardiogr       Date:  2010-08-17

4.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

5.  Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease.

Authors:  W Hayashida; C van Eyll; M F Rousseau; H Pouleur
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study.

Authors:  S J Dong; J H MacGregor; A P Crawley; E McVeigh; I Belenkie; E R Smith; J V Tyberg; R Beyar
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

7.  The influence of LV geometry on the occurrence of abnormal exercise tests in athletes.

Authors:  Danny A J P van de Sande; Jan Hoogsteen; Pieter A Doevendans; Hareld M C Kemps
Journal:  BMC Cardiovasc Disord       Date:  2019-01-06       Impact factor: 2.298

Review 8.  The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.

Authors:  Jay M Edelberg; Amy J Sehnert; Matthew E Mealiffe; Carlos L Del Rio; Robert McDowell
Journal:  Am J Cardiovasc Drugs       Date:  2022-04-18       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.